Recursion CEO Chris Gibson talks integrating AI into drug development process [Video]

Chris Gibson, Recursion Pharmaceuticals CEO, joins ‘Closing Bell Overtime’ to talk its partnership with Nvidia, its investors day, drug discovery and more.